What can we learn from negative clinical trials in systemic sclerosis?
Veale, D.J.
Clinical and Experimental Rheumatology 28(2 Suppl 58: S1-S4
2010
ISSN/ISBN: 0392-856X PMID: 20576207 Document Number: 639722
Document emailed within 1 workday
Related Documents
Merkel, P.A.; Clements, P.J.; Reveille, J.D.; Suarez-Almazor, M.E.; Valentini, G.; Furst, D.E. 2003: Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6 Journal of Rheumatology 30(7): 1630-1647Del Rosso, J.Q. 2013: What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials Journal of Drugs in Dermatology: Jdd 12(6): 609-610
Yagi-Numata, N.; Matsushita, T.; Takehara, K.; Hamaguchi, Y. 2019: Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis Clinical and Experimental Rheumatology 37 Suppl 119(4): 23-31
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548
López-Jiménez, F.; Paniagua, D.; Lamas, G.A. 1998: Interpretation of negative clinical trials Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(5): 435-440
Lebrun, C. 2001: Beta-interferon clinical trials using MRI in patients with multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 761-767
Bergamaschi, R.; Citterio, A.; Filippini, G.; Cosi, V. 1993: Clinical trials in multiple sclerosis: a critical review (1970-1990) Acta Neurologica 15(6): 462-474
Castrejón, I.; Tani, C.; Jolly, M.; Huang, A.; Mosca, M. 2014: Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care Clinical and Experimental Rheumatology 32(5 Suppl 85: S
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Generini, S.; Fiori, G.; Moggi Pignone, A.; Matucci Cerinic, M.; Cagnoni, M. 1999: Systemic sclerosis. a clinical overview Advances in Experimental Medicine and Biology 455: 73-83
Murata, M.; Sato, S.; Komura, K.; Shirasaki, F.; Hasegawa, M.; Takehara, K. 2005: Clinical characteristics of juvenile systemic sclerosis in Japanese Journal of Rheumatology 32(9): 1850-1852
Radić, M.; Kaliterna, D.M.ć; Fabijanić, D.; Radić, J. 2010: Systemic sclerosis--pathogenesis, clinical manifestations and treatment Lijecnicki Vjesnik 132(5-6): 162-168
Maddison, P.J. 1991: Clinical, serological, and immunogenetic studies of systemic sclerosis Revue du Rhumatisme et des Maladies Osteo-Articulaires 58(5): 369-370
Kala, R. 1995: What can we learn about mega-trials of drugs? Duodecim; Laaketieteellinen Aikakauskirja 111(8): 671
Stainforth, J.M.; Layton, A.M.; Goodfield, M.J. 1996: Clinical aspects of the use of gamma linolenic acid in systemic sclerosis Acta Dermato-Venereologica 76(2): 144-146
Wu, C.; Wang, Q.; Xu, D.; Li, M.; Hou, Y.; Zeng, X. 2014: The prevalence and clinical significance of arthritis in patients with systemic sclerosis Zhonghua Nei Ke Za Zhi 53(6): 460-463
Boström, H.; Herbai, G. 1979: Scleroderma (progressive systemic sclerosis, PSS)--pathophysiological, clinical and pharmacological aspects Lakartidningen 76(4): 207-210
Mita, S.; Adachi, M.; Tomii, M.; Matsuoka, Y.; Irimajiri, S.; Miyachi, K.; Takano, S.; Matsushima, H.; Hiwatashi, T. 1989: Clinical study on two cases of progressive systemic sclerosis with anti Wa antibody Ryumachi 29(5): 365-370
Nietert, P.J.; Silver, R.M.; Mitchell, H.C.; Shaftman, S.R.; Tilley, B.C. 2005: Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis Journal of Rheumatology 32(10): 1888-1892
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27